- Home
- LEDS vs LGVN Comparison
LEDS vs LGVN Comparison
Compare LEDS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- LGVN
- Stock Information
- Founded
- LEDS 2005
- LGVN 2014
- Country
- LEDS Taiwan
- LGVN United States
- Employees
- LEDS N/A
- LGVN N/A
- Industry
- LEDS Semiconductors
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- LEDS Technology
- LGVN Health Care
- Exchange
- LEDS Nasdaq
- LGVN Nasdaq
- Market Cap
- LEDS 16.1M
- LGVN 16.4M
- IPO Year
- LEDS 2010
- LGVN 2021
- Fundamental
- Price
- LEDS $2.46
- LGVN $0.86
- Analyst Decision
- LEDS
- LGVN Strong Buy
- Analyst Count
- LEDS 0
- LGVN 2
- Target Price
- LEDS N/A
- LGVN $6.50
- AVG Volume (30 Days)
- LEDS 79.8K
- LGVN 329.0K
- Earning Date
- LEDS 11-26-2025
- LGVN 11-11-2025
- Dividend Yield
- LEDS N/A
- LGVN N/A
- EPS Growth
- LEDS N/A
- LGVN N/A
- EPS
- LEDS N/A
- LGVN N/A
- Revenue
- LEDS $31,108,000.00
- LGVN $2,073,000.00
- Revenue This Year
- LEDS N/A
- LGVN N/A
- Revenue Next Year
- LEDS N/A
- LGVN N/A
- P/E Ratio
- LEDS N/A
- LGVN N/A
- Revenue Growth
- LEDS 485.62
- LGVN 68.67
- 52 Week Low
- LEDS $1.09
- LGVN $0.63
- 52 Week High
- LEDS $3.16
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- LEDS 68.65
- LGVN 48.25
- Support Level
- LEDS $2.20
- LGVN $0.73
- Resistance Level
- LEDS $2.64
- LGVN $0.82
- Average True Range (ATR)
- LEDS 0.18
- LGVN 0.03
- MACD
- LEDS 0.04
- LGVN 0.02
- Stochastic Oscillator
- LEDS 85.22
- LGVN 94.35
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.